Summary
Latest filing:
Jennifer Lew files SEC Form 4 reports at Boundless Bio, Inc. (BOLD). 5 SEC Form 4 filings on record going back to 2025, most recently on 15 June 2026. Most recent open-market trade: sold $30K of ANNX on 4 March 2026. Lifetime open-market sales: $73K.
Recent transactions
4The latest 4 SEC Form 4 transactions reported by Jennifer Lew.
Trading pattern
InsiderAlpha's records for Jennifer Lew go back to 2025: 5 primary Form 4 filings, an average of 2.5 per year. No recorded transaction carries a Rule 10b5-1 plan flag. An absent flag does not establish whether a transaction was pre-arranged or discretionary.
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Jennifer Lew files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Muneer A. Satter - $11.97M in ANNX purchases and sales in the last 12 months
- Kevin Tang - $1.57M in BOLD purchases and sales in the last 12 months
- William H. Carson - $173K in ANNX purchases and sales in the last 12 months
- Jung Choi - $138K in ANNX purchases and sales in the last 12 months
- Douglas Love - $100K in ANNX purchases and sales in the last 12 months
- Ted Yednock - $70K in ANNX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Jennifer Lew?
Jennifer Lew is a corporate insider of Boundless Bio, Inc. (BOLD). InsiderAlpha holds 5 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Jennifer Lew last file a Form 4?
The most recent primary Form 4 on record is dated 15 June 2026, one of 5 filings going back to 2025.
Has Jennifer Lew been buying or selling stock?
Recorded transactions: 0 open-market purchases and 3 open-market sales ($73K) across all tracked filings.